Login
$NIHK
$0.00 +$0.00 (30.43%) Close

Consolidated Balance Sheets

In millions of USD; shares in millions, except per-share amounts
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
Q2 FY2021
As of Jun 30, 2021
Q4 FY2020
As of Dec 31, 2020
Q4 FY2019
As of Dec 31, 2019
Q4 FY2018
As of Dec 31, 2018
ASSETS
Current Assets:
Cash and cash equivalents
Installment Receivable (Current Portion) & Investments
Total Current Assets
Accrued Interest Receivable
Investments - unrelated parties
Nonrelated Party
Total investments - unrelated parties
Fixed assets - net
Long term Notes Receivable - related parties
Entrepreneurship Development
Related Party
Total long term Notes Receivable - related parties
Other Notes Receivable - related parties
Long term Investments - related parties
Related Party
Total long term Investments - related parties
Installment Receivable
Total assets
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)
Current Liabilities:
Accrued expenses
Marginal loan payable
Other current liabilities
Total Current Liabilities
Long-Term Liabilities:
Notes payable
Line of credit - related party
Long-term liability payable
Long-Term Liabilities - Notes payable
Common stock ($0.001 par value)
Preferred stock, $.001 par value, 1,000,000 and 10,000,000 shares authorized, 1 issued and outstanding as at December 31, 2020 and 2019 respectively.
Common Stock, $0.001 par value, 1,200,000,000 and 200,000,000 shares authorized, 177,922,436 and 169,922,436 issued and outstanding as at December 31, 2020 and 2019 respectively.
Total Liabilities
STOCKHOLDERS’ EQUITY (DEFICIT)
Common Stock, $0.001 par value, 200,000,000 shares authorized, 182,370,497 issued and outstanding as at June 30, 2025 and December 31, 2024.
Additional paid in capital
Accumulated deficit
Total Stockholders’ Equity
Total Liabilities and Stockholders’ Equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support